NCT02701361

Brief Summary

Many survivors of the intensive care unit (ICU) suffer from persistent symptoms of depression, anxiety, and post-traumatic stress disorder (PTSD). In this study, the investigators will test the impact of mindfulness to address this distress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2016

Completed
6 days until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 8, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2017

Completed
6 months until next milestone

Results Posted

Study results publicly available

January 10, 2018

Completed
Last Updated

February 7, 2018

Status Verified

January 1, 2018

Enrollment Period

1.2 years

First QC Date

February 24, 2016

Results QC Date

November 15, 2017

Last Update Submit

January 11, 2018

Conditions

Keywords

mindfulnesscritical illnessintensive care unitmindfulness-based stress reduction

Outcome Measures

Primary Outcomes (10)

  • Percent of Eligible Participants Who Provided Consent

    Percent of eligible participants who provided consent. Because this includes eligible yet not-as-yet randomized participants, there are no study arm differences analyzed. This is a feasibility measure. Target is 70%.

    pre-randomization

  • Percent of Eligible Participants Who Provide Informed Consent and Were Randomized

    Percent of eligible participants who provide informed consent and were randomized. A measure of feasibility. Target is 60%.

    randomization

  • Client Satisfaction Questionnaire (CSQ) Score

    Acceptability was measured with the adapted Client Satisfaction Questionnaire (CSQ), which assesses credibility and satisfaction (range 9 \[low, a worse outcome\] to 36 \[highest, a better outcome\]). Target is mean score \>10.

    1 month post-randomization

  • System Usability Scale (SUS)

    Usability of the mobile app was assessed with open-ended participant feedback and with the 10-item System Usability Scale (SUS; 0 \[lowest\] to 100 \[highest\]). A SUS score above a 68 would be considered above average and anything below 68 is below average.

    1 month post-randomization

  • Percent of Randomized Participants Who Drop Out of Study

    A feasibility measure. Target is 20% or less.

    baseline, end of study (approx. 4 months)

  • Percent of Participants Who Have Neither Dropped Out Nor Died Who Complete Telephone Interviews

    Percent of participants who have neither dropped out nor died who complete telephone interviews. A feasibility measure. Target is 75%.

    baseline, end of study (approx. 4 months)

  • Percent of Participants in the Self-directed MBT Group Who Complete Weekly Surveys

    A feasibility measure. Target is 60%. Note that this is for completion of ALL FOUR weekly surveys.

    baseline, end of study (approx. 4 months)

  • Percentage of Self-directed MBT Sessions Attended by Eligible Participants

    A feasibility measure. Target is 50% among those who neither dropped out nor died.

    baseline, end of study (approx. 4 months)

  • Visual Analog Satisfaction Scale

    A measure of acceptability of the intervention. Target mean score is 75% or greater.

    after intervention completion, up to 8 weeks post-randomization

  • Number of Participant Clicks on Study Website

    A usability measure obtained using Google Analytics.

    baseline, end of study (approx. 4 months)

Secondary Outcomes (6)

  • Change in Psychological Distress Symptoms as Measured by the Patient Health Questionnaire (PHQ) Scale

    Between randomization and 3 months post-randomization

  • Change in Distress Associated With Physical Symptoms

    Between randomization and 3 months post-randomization

  • Change in Mindfulness Skills

    Between randomization and 3 months post-randomization

  • Change in Psychological Distress Symptoms as Measured by the GAD-7

    Between randomization and 3 months post-randomization

  • Change in Psychological Distress Symptoms as Measured by the PTSS

    Between randomization and 3 months post-randomization

  • +1 more secondary outcomes

Other Outcomes (1)

  • Usability Themes Developed From Semi-structured Participant Interviews

    end of study

Study Arms (3)

Education group

ACTIVE COMPARATOR

A care condition in which an educational program relevant to critical illness is presented in a web-based format similar to the other arms. Telephone calls will be used to answer questions and assist with web content.

Behavioral: education

Standard mindfulness

EXPERIMENTAL

Receives audiovisual mindfulness content via internet plus 1 call per week from a trained mindfulness expert.

Behavioral: standard mindfulness

Mobile mindfulness

EXPERIMENTAL

Receives audiovisual mindfulness content via web-app. Will receive at least 1 call from a trained mindfulness expert, though up to 4 total calls based on symptoms / request.

Behavioral: mobile mindfulness

Interventions

Receives audiovisual mindfulness content via internet plus call depending on symptoms or request.

Mobile mindfulness

Receives weekly calls from mindfulness expert for 4 weeks.

Standard mindfulness
educationBEHAVIORAL

Receives web-based content about critical illness topics. Also receives two calls from study team to describe materials and answer questions about materials.

Education group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years
  • acute cardiorespiratory failure managed in an intensive care unit
  • reside at home before hospital admission (i.e., not in a facility)
  • Respiratory failure, ≥1 of these:
  • mechanical ventilation via endotracheal tube for ≥ 12 hours
  • non-invasive ventilation (CPAP, BiPAP) for \> 4 hours in a 24 hour period provided for acute respiratory failure in an ICU (not for obstructive sleep apnea or other stable use)
  • high flow nasal cannula or face mask O2 with FiO2 ≥ 0.5 for ≥4 hours
  • Cardiac / circulatory failure, ≥1 of these:
  • use of vasopressors for shock of any etiology for \> 1 hour
  • use of inotropes for shock of any etiology for \> 1 hour
  • use of aortic balloon pump for cardiogenic shock

You may not qualify if:

  • pre-existing significant cognitive impairment (e.g., dementia)
  • treated for severe or unstable mental illness within 6 months preceding current admission (e.g., depression with psychosis, suicidality, schizophrenia as per medical record)
  • hospital inpatient within 3 months before current admission
  • active substance abuse at the time of admission
  • lack of decisional capacity \[\*'Decisional capacity' is defined as the ability to participate in effective decision making and provide informed consent. That is, in the judgment of the examiner, the patient, after reading the IRB approved patient consent document (or having it read to them) can (a) generally understand the terms of participation in the study: the purpose of the study, what will be required of study participants; the potential risks, benefits and alternatives of study participation; pros \& cons of study involvement and (b) can communicate a choice in his/her own words (or write on a communication board)\]
  • current significant cognitive impairment (≥3 errors on the Callahan cognitive status screen; see below)
  • need for a translator because of poor English fluency \[many study instruments are not validated in other languages\]
  • expected survival \<6 months per attending physician
  • ICU length of stay \>30 days
  • lack of either:
  • reliable or sufficient smartphone with cellular data plan or
  • reliable computer online access plus telephone access
  • unable to complete study procedures as determined by study staff
  • discharge to a location other than a home setting
  • complex medical care expected soon after discharge (e.g., multiple planned surgeries, transplantation evaluation (including outpatient daily cardiopulmonary rehabilitation), extensive travel needs for hemodialysis, disruptive chemotherapy or XRT regimen, etc)
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Duke University

Durham, North Carolina, 27710, United States

Location

University of Washington

Seattle, Washington, 98195, United States

Location

Related Publications (2)

  • Cox CE, Porter LS, Buck PJ, Hoffa M, Jones D, Walton B, Hough CL, Greeson JM. Development and preliminary evaluation of a telephone-based mindfulness training intervention for survivors of critical illness. Ann Am Thorac Soc. 2014 Feb;11(2):173-81. doi: 10.1513/AnnalsATS.201308-283OC.

    PMID: 24303911BACKGROUND
  • Cox CE, Hough CL, Jones DM, Ungar A, Reagan W, Key MD, Gremore T, Olsen MK, Sanders L, Greeson JM, Porter LS. Effects of mindfulness training programmes delivered by a self-directed mobile app and by telephone compared with an education programme for survivors of critical illness: a pilot randomised clinical trial. Thorax. 2019 Jan;74(1):33-42. doi: 10.1136/thoraxjnl-2017-211264. Epub 2018 May 23.

MeSH Terms

Conditions

DepressionAnxiety DisordersStress Disorders, Post-TraumaticCritical Illness

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersStress Disorders, TraumaticTrauma and Stressor Related DisordersDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Results Point of Contact

Title
Christopher Cox
Organization
Duke University Health System

Study Officials

  • Christopher E Cox, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2016

First Posted

March 8, 2016

Study Start

March 1, 2016

Primary Completion

May 1, 2017

Study Completion

July 5, 2017

Last Updated

February 7, 2018

Results First Posted

January 10, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations